Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, doubl

Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Strusberg; Patrick Durez; Peter Nash; Eric Jason B. Amante; Melvin Churchill; Won Park; Bernardo Antonio Pons-Estel; Mittie K. Doyle; Sudha Visvanathan; Weichun Xu; Mahboob U. Rahman

doi:10.1002/art.27705

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, doubl

Arthritis & Rheumatism ◽

10.1002/art.27705 ◽

2010 ◽

Vol 62 (9) ◽

pp. 2812-2812

Author(s):

Paul Emery ◽

Roy M. Fleischmann ◽

Larry W. Moreland ◽

Elizabeth C. Hsia ◽

Ingrid Strusberg ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Active Rheumatoid Arthritis ◽

Phase Iii ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study

Arthritis Research & Therapy ◽

10.1186/s13075-015-0516-6 ◽

2015 ◽

Vol 17 (1) ◽

Cited By ~ 28

Author(s):

Josef S Smolen ◽

Jonathan Kay ◽

Mittie Doyle ◽

Robert Landewé ◽

Eric L Matteson ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Active Rheumatoid Arthritis ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis

Arthritis & Rheumatism ◽

10.1002/art.1780390702 ◽

1996 ◽

Vol 39 (7) ◽

pp. 1077-1081 ◽

Cited By ~ 217

Author(s):

Paul P. Tak ◽

Peter C. Taylor ◽

Ferdinand C. Breedveld ◽

Tom J. M. Smeets ◽

Mohamed R. Daha ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Adhesion Molecules ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Antibody Treatment ◽

Monoclonal Antibody Treatment ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Arthritis & Rheumatism ◽

10.1002/art.10697 ◽

2003 ◽

Vol 48 (1) ◽

pp. 35-45 ◽

Cited By ~ 1138

Author(s):

Michael E. Weinblatt ◽

Edward C. Keystone ◽

Daniel E. Furst ◽

Larry W. Moreland ◽

Michael H. Weisman ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Sustained secretion of anti-tumor necrosis factor α monoclonal antibody fromex vivogenetically engineered dermal tissue demonstrates therapeutic activity in mouse model of rheumatoid arthritis

The Journal of Gene Medicine ◽

10.1002/jgm.2965 ◽

2017 ◽

Vol 19 (8) ◽

pp. e2965 ◽

Cited By ~ 3

Author(s):

Inbal Zafir-Lavie ◽

Reem Miari ◽

Shay Sherbo ◽

Simi Krispel ◽

Osnat Tal ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Mouse Model ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Therapeutic Activity ◽

Dermal Tissue ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

Arthritis & Rheumatism ◽

10.1002/1529-0131(200011)43:11<2383::aid-anr2>3.0.co;2-d ◽

2000 ◽

Vol 43 (11) ◽

pp. 2383-2390 ◽

Cited By ~ 325

Author(s):

P. J. Charles ◽

R. J. T. Smeenk ◽

J. De Jong ◽

M. Feldmann ◽

R. N. Maini

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Controlled Trials ◽

Open Label ◽

Double Stranded Dna ◽

Factor Α ◽

Necrosis Factor

Download Full-text

ANTI-TUMOR NECROSIS FACTOR-α MONOCLONAL ANTIBODY THERAPY FOR RHEUMATOID ARTHRITIS

Rheumatic Disease Clinics of North America ◽

10.1016/s0889-857x(05)70028-4 ◽

1998 ◽

Vol 24 (3) ◽

pp. 593-614 ◽

Cited By ~ 37

Author(s):

Arthur F. Kavanaugh

Keyword(s):

Rheumatoid Arthritis ◽

Monoclonal Antibody ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Antibody Therapy ◽

Monoclonal Antibody Therapy ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Remission of anti‐tumor necrosis factor‐α antibody‐induced palmoplantar pustulosis with the Janus kinase inhibitor baricitinib in a patient with rheumatoid arthritis

The Journal of Dermatology ◽

10.1111/1346-8138.15860 ◽

2021 ◽

Author(s):

Shinichi Imafuku ◽

Akira Maeyama

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Palmoplantar Pustulosis ◽

Janus Kinase Inhibitor ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Tumor necrosis factor α 5′-flanking region, tumor necrosis factor receptor II, and HLA–DRB1 polymorphisms in Japanese patients with rheumatoid arthritis

Arthritis & Rheumatism ◽

10.1002/1529-0131(200004)43:4<753::aid-anr5>3.0.co;2-o ◽

2000 ◽

Vol 43 (4) ◽

pp. 753 ◽

Cited By ~ 40

Author(s):

Tsukasa Shibue ◽

Naoyuki Tsuchiya ◽

Tae Komata ◽

Masaki Matsushita ◽

Michiko Shiota ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Tumor Necrosis Factor Receptor ◽

Japanese Patients ◽

Flanking Region ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Anti-inflammatory drugs and tumor necrosis factor-α production from monocytes: role of transcription factor NF-κB and implication for rheumatoid arthritis therapy

European Journal of Pharmacology ◽

10.1016/j.ejphar.2004.07.101 ◽

2004 ◽

Vol 501 (1-3) ◽

pp. 199-208 ◽

Cited By ~ 28

Author(s):

Luisa Lavagno ◽

Gabriele Gunella ◽

Claudio Bardelli ◽

Simona Spina ◽

Luigia Grazia Fresu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Transcription Factor ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Inflammatory Drugs ◽

Anti Inflammatory ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Anti-tumor necrosis factor α therapy in rheumatoid arthritis: Hitting two birds with one stone?

Arthritis & Rheumatism ◽

10.1002/art.20406 ◽

2004 ◽

Vol 51 (3) ◽

pp. 309-310 ◽

Cited By ~ 4

Author(s):

Kenneth J. Warrington

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Factor Α ◽

Necrosis Factor

Download Full-text